Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nestoras Mathioudakis

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Diabetes Care|June 4, 2025
Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort StudyDaniel R Morales, Fan Bu, Benjamin Viernes, et al.
Science Bulletin|February 13, 2025
Large language models for diabetes training: a prospective studyHaoxuan Li, Zehua Jiang, Zhouyu Guan, et al.
BMJ Open Diabetes Research & Care|November 5, 2025
Semaglutide and diabetic retinopathy: an OHDSI network studyCindy Xinji Cai, Akihiko Nishimura, Sally Baxter, et al.
Ophthalmology|June 2, 2026
Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network StudyCindy X Cai, Brian Toy, Benjamin Martin, et al.
Journal of Diabetes Science and Technology|March 7, 2026
Integrating the Glycemia Risk Index Into Clinical Practice and Research: A Consensus ReportGuillermo E Umpierrez, Viral N Shah, Veronica Brady, et al.
BMJ Medicine|October 13, 2023
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DMRohan Khera, Lovedeep Singh Dhingra, Arya Aminorroaya, et al.
Journal of the American College of Cardiology|August 28, 2024
Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DMRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM StudyRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.
JAMA Ophthalmology|February 20, 2025
Semaglutide and Nonarteritic Anterior Ischemic Optic NeuropathyCindy X Cai, Michelle Hribar, Sally Baxter, et al.
Journal of Diabetes Science and Technology|January 14, 2026
Research Code Sharing in Support of Gold Standard ScienceDavid C Klonoff, Juan Espinoza, Julia K Mader, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Diabetes Care|June 4, 2025
Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort StudyDaniel R Morales, Fan Bu, Benjamin Viernes, et al.
Science Bulletin|February 13, 2025
Large language models for diabetes training: a prospective studyHaoxuan Li, Zehua Jiang, Zhouyu Guan, et al.
BMJ Open Diabetes Research & Care|November 5, 2025
Semaglutide and diabetic retinopathy: an OHDSI network studyCindy Xinji Cai, Akihiko Nishimura, Sally Baxter, et al.
Ophthalmology|June 2, 2026
Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network StudyCindy X Cai, Brian Toy, Benjamin Martin, et al.
Journal of Diabetes Science and Technology|March 7, 2026
Integrating the Glycemia Risk Index Into Clinical Practice and Research: A Consensus ReportGuillermo E Umpierrez, Viral N Shah, Veronica Brady, et al.
BMJ Medicine|October 13, 2023
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DMRohan Khera, Lovedeep Singh Dhingra, Arya Aminorroaya, et al.
Journal of the American College of Cardiology|August 28, 2024
Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DMRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM StudyRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.
JAMA Ophthalmology|February 20, 2025
Semaglutide and Nonarteritic Anterior Ischemic Optic NeuropathyCindy X Cai, Michelle Hribar, Sally Baxter, et al.
Journal of Diabetes Science and Technology|January 14, 2026
Research Code Sharing in Support of Gold Standard ScienceDavid C Klonoff, Juan Espinoza, Julia K Mader, et al.
Pageof 11